Roche releases two new antibodies to identify key clinical mutations in patients with brain cancer
Roche has introduced the IDH1 R132H (MRQ-67) Rabbit Monoclonal Primary Antibody and the ATRX Rabbit Polyclonal Antibody to identify mutation status in patients diagnosed with brain cancer.